Ai Mediq is pleased to announce participation in the annual meeting of European Society of Cardiology (ESC Congress) 2019 which will take place this time in Paris, France. For the first time ESC Congress will be held jointly with World Cardiological Congress (WCC) that will bring together two most prominent annual events in the world of cardiology. As the booth numbers are still being assigned…
Ai Mediq took part in the 2019 Congress of the European Cardiology Society in Paris, France. This year Ai Mediq has had detailed feedback from key opinion leaders and are looking into possible options to introduce ReOxy, our core product, to rehabilitation of chronic heart failure patients. We believe our innovative approach will be able to assist with resolving the ever-growing pain of heart failure…
Ai Mediq is looking forward to seeing all our existing partners and new potential collaborators at joint booth of Ministry of Economy of Grand Duchy of Luxembourg tomorrow morning during opening of the Exhibition. The booth number remained the same A74 in Hall 3, so you should have no problems locating us. See you in Dusseldorf. P.S. Distributors wanted.
Currently, all efforts are focused on patients with acute diseases. All hospitals are crowded with severe patients with COVID-19 who need emergency care to save their lives. On the other hand, the number of people recovering from the virus is also steadily growing. Indeed, most of the patients have mild symptoms and it is expected that they will not have any complications after recovery. Nevertheless,…
It is was our pleasure to take part in the meeting and present the Intermittent Hypoxic Training Method in one of the well-known Liliane Goschy-FRITZ Institute in Baden-Baden, Germany on the 15th if July 2020. Liliane Goschy-FRITZ Institute provides a unique range of service areas for a healthy, powerful, and aesthetic body, individually combined in a flexible structure: a holistic concept of physiotherapy, personal training,…
Luxembourg, 23rd November Ai Mediq S.A. is pleased to announce the new stage of scientific cooperation with the Universitätsklinikum Hamburg-Eppendorf (UKE). Together with Dr. Sina Cathérine Rosenkranz we will be looking into potential perspectives of Interval Hypoxic Therapy in the treatment of multiple sclerosis. The pilot clinical trial will be conducted by the Institut für Neuroimmunologie und Multiple Sklerose (INIMS) and will be performed under the supervision of Prof.Dr.med.…
Ai Mediq is publishing a translation of publication by Prof. Oleg S. Glazachev for RBC.RU regarding the implications of COVID-19 and therapeutic potential of application of ReOxy device to rehabilitate the patients. What are the health consequences of the virus, and what can be done to recover from a serious illness? Oleg Glazachev, Professor of the Department of Physiology, Sechenov University, helped RBC Style to…
